United Therapeutics Corporation Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent
United Therapeutics Corporation (UTHR) reported Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent of $100.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent · last filed 2026-08-05
- United Therapeutics Corporation other comprehensive (income) loss, defined benefit plan, after tax and reclassification adjustment, attributable to parent for the quarter ending 2026-06-30 was $100.00K, a 75.00% decline year-over-year.
- United Therapeutics Corporation other comprehensive (income) loss, defined benefit plan, after tax and reclassification adjustment, attributable to parent for the quarter ending 2026-03-31 was $100.00K, a 96.88% decline year-over-year.
- United Therapeutics Corporation other comprehensive (income) loss, defined benefit plan, after tax and reclassification adjustment, attributable to parent for the quarter ending 2025-12-31 was $200.00K, a 80.00% decline year-over-year.
- United Therapeutics Corporation other comprehensive (income) loss, defined benefit plan, after tax and reclassification adjustment, attributable to parent for the quarter ending 2025-09-30 was $1.60M, a 45.45% increase year-over-year.
- United Therapeutics Corporation other comprehensive (income) loss, defined benefit plan, after tax and reclassification adjustment, attributable to parent for fiscal 2025 was $5.40M, a 10.20% increase from fiscal 2024.
- United Therapeutics Corporation other comprehensive (income) loss, defined benefit plan, after tax and reclassification adjustment, attributable to parent for fiscal 2024 was $4.90M, a 68.97% increase from fiscal 2023.
- United Therapeutics Corporation other comprehensive (income) loss, defined benefit plan, after tax and reclassification adjustment, attributable to parent for fiscal 2023 was $2.90M.
- United Therapeutics Corporation other comprehensive (income) loss, defined benefit plan, after tax and reclassification adjustment, attributable to parent for fiscal 2022 was -$19.30M.
| Period end | Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent 3 month | Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent 3 month as first filed | Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent 6 month | Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent 6 month as first filed | Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent 9 month | Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent 9 month as first filed | Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent 12 month | Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $100.00K 10-Q · filed 2026-08-05 | $200.00K 10-Q · filed 2026-08-05 | $400.00K derived: sum of 3 quarters · filed 2026-08-05 | $2.00M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2026-03-31 | $100.00K 10-Q · filed 2026-05-06 | $300.00K derived: sum of 2 quarters · filed 2026-05-06 | $1.90M derived: sum of 3 quarters · filed 2026-05-06 | $2.30M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $1.80M derived: sum of 2 quarters · filed 2026-02-25 | $2.20M derived: sum of 3 quarters · filed 2026-08-05 | $5.40M 10-K · filed 2026-02-25 | ||||
| 2025-09-30 | $1.60M 10-Q · filed 2025-10-29 | $2.00M derived: sum of 2 quarters · filed 2026-08-05 | $5.20M 10-Q · filed 2025-10-29 | $6.20M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-06-30 | $400.00K 10-Q · filed 2026-08-05 | $3.60M 10-Q · filed 2026-08-05 | $4.60M derived: sum of 3 quarters · filed 2026-08-05 | $5.70M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-03-31 | $3.20M 10-Q · filed 2026-05-06 | $4.20M derived: sum of 2 quarters · filed 2026-05-06 | $5.30M derived: sum of 3 quarters · filed 2026-05-06 | $6.40M derived: sum of 4 quarters · filed 2026-05-06 | ||||
| 2024-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $2.10M derived: sum of 2 quarters · filed 2026-02-25 | $3.20M derived: sum of 3 quarters · filed 2026-02-25 | $4.90M 10-K · filed 2026-02-25 | ||||
| 2024-09-30 | $1.10M 10-Q · filed 2025-10-29 | $2.20M derived: sum of 2 quarters · filed 2025-10-29 | $3.90M 10-Q · filed 2025-10-29 | $1.90M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2024-06-30 | $1.10M 10-Q · filed 2025-07-30 | $2.80M 10-Q · filed 2025-07-30 | $800.00K derived: sum of 3 quarters · filed 2026-02-25 | $1.70M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2024-03-31 | $1.70M 10-Q · filed 2025-04-30 | -$300.00K derived: sum of 2 quarters · filed 2026-02-25 | $600.00K derived: sum of 3 quarters · filed 2026-02-25 | $1.40M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2023-12-31 | -$2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$1.10M derived: sum of 2 quarters · filed 2026-02-25 | -$300.00K derived: sum of 3 quarters · filed 2026-02-25 | $2.90M 10-K · filed 2026-02-25 | ||||
| 2023-09-30 | $900.00K 10-Q · filed 2024-10-30 | $1.70M derived: sum of 2 quarters · filed 2024-10-30 | $4.90M 10-Q · filed 2024-10-30 | -$13.70M derived: sum of 4 quarters · filed 2025-02-26 | ||||
| 2023-06-30 | $800.00K 10-Q · filed 2024-07-31 | $4.00M 10-Q · filed 2024-07-31 | -$14.60M derived: sum of 3 quarters · filed 2025-02-26 | -$14.80M derived: sum of 4 quarters · filed 2025-02-26 | ||||
| 2023-03-31 | $3.20M 10-Q · filed 2024-05-01 | -$15.40M derived: sum of 2 quarters · filed 2025-02-26 | -$15.60M derived: sum of 3 quarters · filed 2025-02-26 | -$15.80M derived: sum of 4 quarters · filed 2025-02-26 | ||||
| 2022-12-31 | -$18.60M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | -$18.80M derived: sum of 2 quarters · filed 2025-02-26 | -$19.00M derived: sum of 3 quarters · filed 2025-02-26 | -$19.30M 10-K · filed 2025-02-26 | ||||
| 2022-09-30 | -$200.00K 10-Q · filed 2023-11-01 | -$400.00K derived: sum of 2 quarters · filed 2023-11-01 | -$700.00K 10-Q · filed 2023-11-01 | -$6.30M derived: sum of 4 quarters · filed 2024-02-21 | ||||
| 2022-06-30 | -$200.00K 10-Q · filed 2023-08-02 | -$500.00K 10-Q · filed 2023-08-02 | -$6.10M derived: sum of 3 quarters · filed 2024-02-21 | -$6.20M derived: sum of 4 quarters · filed 2024-02-21 | ||||
| 2022-03-31 | -$300.00K 10-Q · filed 2023-05-03 | -$5.90M derived: sum of 2 quarters · filed 2024-02-21 | -$6.00M derived: sum of 3 quarters · filed 2024-02-21 | -$6.20M derived: sum of 4 quarters · filed 2024-02-21 | ||||
| 2021-12-31 | -$5.60M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | -$5.70M derived: sum of 2 quarters · filed 2024-02-21 | -$5.90M derived: sum of 3 quarters · filed 2024-02-21 | -$6.20M 10-K · filed 2024-02-21 | ||||
| 2021-09-30 | -$100.00K 10-Q · filed 2022-11-02 | -$300.00K derived: sum of 2 quarters · filed 2022-11-02 | -$600.00K 10-Q · filed 2022-11-02 | $7.20M derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2021-06-30 | -$200.00K 10-Q · filed 2022-08-03 | -$500.00K 10-Q · filed 2022-08-03 | $7.30M derived: sum of 3 quarters · filed 2023-02-22 | $7.00M derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2021-03-31 | -$300.00K 10-Q · filed 2022-05-04 | $7.50M derived: sum of 2 quarters · filed 2023-02-22 | $7.20M derived: sum of 3 quarters · filed 2023-02-22 | $6.90M derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2020-12-31 | $7.80M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $7.50M derived: sum of 2 quarters · filed 2023-02-22 | $7.20M derived: sum of 3 quarters · filed 2023-02-22 | $6.70M 10-K · filed 2023-02-22 | ||||
| 2020-09-30 | -$300.00K 10-Q · filed 2021-11-03 | -$600.00K derived: sum of 2 quarters · filed 2021-11-03 | -$1.10M 10-Q · filed 2021-11-03 | $9.00M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2020-06-30 | -$300.00K 10-Q · filed 2021-08-04 | -$800.00K 10-Q · filed 2021-08-04 | $9.30M derived: sum of 3 quarters · filed 2022-02-24 | $9.40M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2020-03-31 | -$500.00K 10-Q · filed 2021-05-05 | $9.60M derived: sum of 2 quarters · filed 2022-02-24 | $9.70M derived: sum of 3 quarters · filed 2022-02-24 | $11.90M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2019-12-31 | $10.10M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $10.20M derived: sum of 2 quarters · filed 2022-02-24 | $12.40M derived: sum of 3 quarters · filed 2022-02-24 | $12.30M 10-K · filed 2022-02-24 | ||||
| 2019-09-30 | $100.00K 10-Q · filed 2020-10-28 | $2.30M derived: sum of 2 quarters · filed 2020-10-28 | $2.20M 10-Q · filed 2020-10-28 | -$8.90M derived: sum of 4 quarters · filed 2021-02-24 | ||||
| 2019-06-30 | $2.20M 10-Q · filed 2020-07-29 | $2.10M 10-Q · filed 2020-07-29 | -$9.00M derived: sum of 3 quarters · filed 2021-02-24 | -$9.40M derived: sum of 4 quarters · filed 2021-02-24 | ||||
| 2019-03-31 | -$100.00K 10-Q · filed 2020-04-29 | -$11.20M derived: sum of 2 quarters · filed 2021-02-24 | -$11.60M derived: sum of 3 quarters · filed 2021-02-24 | -$11.90M derived: sum of 4 quarters · filed 2021-02-24 | ||||
| 2018-12-31 | -$11.10M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | -$11.50M derived: sum of 2 quarters · filed 2021-02-24 | -$11.80M derived: sum of 3 quarters · filed 2021-02-24 | -$12.10M 10-K · filed 2021-02-24 | ||||
| 2018-09-30 | -$400.00K 10-Q · filed 2019-10-30 | -$700.00K derived: sum of 2 quarters · filed 2019-10-30 | -$1.00M 10-Q · filed 2019-10-30 | $400.00K derived: sum of 4 quarters · filed 2020-02-26 | ||||
| 2018-06-30 | -$300.00K 10-Q · filed 2019-07-31 | -$600.00K 10-Q · filed 2019-07-31 | $800.00K derived: sum of 3 quarters · filed 2020-02-26 | $700.00K derived: sum of 4 quarters · filed 2020-02-26 | ||||
| 2018-03-31 | -$300.00K 10-Q · filed 2019-05-01 | $1.10M derived: sum of 2 quarters · filed 2020-02-26 | $1.00M derived: sum of 3 quarters · filed 2020-02-26 | $800.00K derived: sum of 4 quarters · filed 2020-02-26 | ||||
| 2017-12-31 | $1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | $1.30M derived: sum of 2 quarters · filed 2020-02-26 | $1.10M derived: sum of 3 quarters · filed 2020-02-26 | $1.10M 10-K · filed 2020-02-26 | ||||
| 2017-09-30 | -$100.00K 10-Q · filed 2018-10-31 | -$300.00K derived: sum of 2 quarters · filed 2018-10-31 | -$300.00K 10-Q · filed 2018-10-31 | |||||
| 2017-06-30 | -$200.00K 10-Q · filed 2018-08-01 | -$200.00K 10-Q · filed 2018-08-01 | ||||||
| 2016-12-31 | -$200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $900.00K derived: sum of 2 quarters · filed 2019-02-27 | -$6.40M derived: sum of 3 quarters · filed 2019-02-27 | -$6.60M 10-K · filed 2019-02-27 | ||||
| 2016-09-30 | $1.10M 10-Q · filed 2017-10-25 | -$6.20M derived: sum of 2 quarters · filed 2017-10-25 | -$6.40M 10-Q · filed 2017-10-25 | -$9.50M derived: sum of 4 quarters · filed 2018-02-21 | ||||
| 2016-06-30 | -$7.30M 10-Q · filed 2017-07-27 | -$7.50M 10-Q · filed 2017-07-27 | -$10.60M derived: sum of 3 quarters · filed 2018-02-21 | -$10.70M derived: sum of 4 quarters · filed 2018-02-21 | ||||
| 2016-03-31 | -$200.00K 10-Q · filed 2017-04-26 | -$3.30M derived: sum of 2 quarters · filed 2018-02-21 | -$3.40M derived: sum of 3 quarters · filed 2018-02-21 | -$3.60M derived: sum of 4 quarters · filed 2018-02-21 | ||||
| 2015-12-31 | -$3.10M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-21 | -$3.20M derived: sum of 2 quarters · filed 2018-02-21 | -$3.40M derived: sum of 3 quarters · filed 2018-02-21 | -$1.60M 10-K · filed 2018-02-21 | -$1.70M 10-K · filed 2016-02-25 | |||
| 2015-09-30 | -$100.00K 10-Q · filed 2016-10-27 | -$148.00K 10-Q · filed 2015-10-27 | -$300.00K derived: sum of 2 quarters · filed 2016-10-27 | $1.50M 10-Q · filed 2016-10-27 | $1.48M 10-Q · filed 2015-10-27 | -$1.52M derived: sum of 4 quarters · filed 2017-02-22 | ||
| 2015-06-30 | -$200.00K 10-Q · filed 2016-07-28 | -$148.00K 10-Q · filed 2015-07-28 | $1.60M 10-Q · filed 2016-07-28 | $1.63M 10-Q · filed 2015-07-28 | -$1.42M derived: sum of 3 quarters · filed 2017-02-22 | -$1.64M derived: sum of 4 quarters · filed 2017-02-22 | ||
| 2015-03-31 | $1.80M 10-Q · filed 2016-04-28 | $1.78M 10-Q · filed 2015-04-28 | -$1.22M derived: sum of 2 quarters · filed 2017-02-22 | -$1.44M derived: sum of 3 quarters · filed 2017-02-22 | -$1.67M derived: sum of 4 quarters · filed 2017-02-22 | |||
| 2014-12-31 | -$3.02M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-22 | -$3.24M derived: sum of 2 quarters · filed 2017-02-22 | -$3.47M derived: sum of 3 quarters · filed 2017-02-22 | -$1.50M 10-K · filed 2017-02-22 | -$1.49M 10-K · filed 2015-02-24 | |||
| 2014-09-30 | -$226.00K 10-Q · filed 2015-10-27 | -$452.00K derived: sum of 2 quarters · filed 2015-10-27 | $1.52M 10-Q · filed 2015-10-27 | -$761.00K derived: sum of 4 quarters · filed 2016-02-25 | ||||
| 2014-06-30 | -$226.00K 10-Q · filed 2015-07-28 | $1.74M 10-Q · filed 2015-07-28 | -$535.00K derived: sum of 3 quarters · filed 2016-02-25 | -$790.00K derived: sum of 4 quarters · filed 2016-02-25 | ||||
| 2014-03-31 | $1.97M 10-Q · filed 2015-04-28 | -$309.00K derived: sum of 2 quarters · filed 2016-02-25 | -$564.00K derived: sum of 3 quarters · filed 2016-02-25 | -$820.00K derived: sum of 4 quarters · filed 2016-02-25 | ||||
| 2013-12-31 | -$2.28M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | -$2.53M derived: sum of 2 quarters · filed 2016-02-25 | -$2.79M derived: sum of 3 quarters · filed 2016-02-25 | -$3.10M 10-K · filed 2016-02-25 | ||||
| 2013-09-30 | -$255.00K 10-Q · filed 2014-10-28 | -$511.00K derived: sum of 2 quarters · filed 2014-10-28 | -$818.00K 10-Q · filed 2014-10-28 | $4.47M derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2013-06-30 | -$256.00K 10-Q · filed 2014-07-29 | -$563.00K 10-Q · filed 2014-07-29 | $4.72M derived: sum of 3 quarters · filed 2015-02-24 | $4.59M derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2013-03-31 | -$307.00K 10-Q · filed 2014-04-29 | $4.98M derived: sum of 2 quarters · filed 2015-02-24 | $4.85M derived: sum of 3 quarters · filed 2015-02-24 | $4.72M derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2012-12-31 | $5.29M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $5.15M derived: sum of 2 quarters · filed 2015-02-24 | $5.02M derived: sum of 3 quarters · filed 2015-02-24 | $4.83M 10-K · filed 2015-02-24 | ||||
| 2012-09-30 | -$131.00K 10-Q · filed 2013-10-29 | -$261.00K derived: sum of 2 quarters · filed 2013-10-29 | -$455.00K 10-Q · filed 2013-10-29 | -$869.00K derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2012-06-30 | -$130.00K 10-Q · filed 2013-07-25 | -$325.00K 10-Q · filed 2013-07-25 | -$738.00K derived: sum of 3 quarters · filed 2014-02-25 | -$882.00K derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2012-03-31 | -$194.00K 10-Q · filed 2013-04-25 | -$608.00K derived: sum of 2 quarters · filed 2014-02-25 | -$752.00K derived: sum of 3 quarters · filed 2014-02-25 | $122.00K derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2011-12-31 | -$414.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | -$558.00K derived: sum of 2 quarters · filed 2014-02-25 | $316.00K derived: sum of 3 quarters · filed 2014-02-25 | $7.00K 10-K · filed 2014-02-25 | ||||
| 2011-09-30 | -$144.00K 10-Q · filed 2012-11-01 | $730.00K derived: sum of 2 quarters · filed 2012-11-01 | $421.00K 10-Q · filed 2012-11-01 | |||||
| 2011-06-30 | $874.00K 10-Q · filed 2012-07-26 | $565.00K 10-Q · filed 2012-07-26 | ||||||
| 2011-03-31 | -$309.00K 10-Q · filed 2012-04-26 | |||||||
| 2010-12-31 | $4.35M 10-K · filed 2013-02-26 | |||||||
| 2009-12-31 | $1.25M 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |